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1. Introduction
Autism is a neurodevelopmental disorder characterized by impaired social interaction, and
verbal and nonverbal communication as well as limited and repetitive behaviours. Although
symptomatology of autism may be noticed around early months, diagnosis generally occurs
around 24-36 months, however in some cases diagnosis may be delayed to adulthood [1].
Since behavioural symptoms and the degree of functional impairment are variable, the au‐
tistic disorder is described as a heterogenous symptom cluster of varying etiological and
pathological basis [2]. Described as a multifactorial disorder created by interaction of neuro‐
logic, immunologic, environmental, and genetic factors, autistic disorder has no definite
cause [3, 4]. In many cases in whom the etiology remains unclear are diagnosed as idiopath‐
ic autism or non-syndromic autism [5, 6]. Seventy percent of cases with idiopathic autism
have basic symptoms without physical abnormalities whereas 30% have complex autism in
which dysmorphic features are detected such as microcephaly and/or structural brain mal‐
formations [7]. Autism is associated with other syndromes such as Fragile X syndrome,
Down Syndrome, and tuberosclerosis in 5-25% of the cases ([8, 9]. Although phenotypic het‐
erogeneity is the biggest challenge for research efforts directed to identify autism etiology
[10], currently it is widely accepted that environmental and genetic factors play essential
role in genesis of autistic disorder thanks to a recent advance in research techniques related
to biological factors and widespread studies in this field [11, 12].
2. Genetics
Autistic disorder is a multifactorial genetic disorder not following classical Mendelian inher‐
itance. Impairment in social interaction and verbal communication as well as genetic differ‐
entiation in rigid-repetitive behaviours indicates that different features in autistic disorder
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may be caused by different genes associated with distinct brain regions and be related to
cognitive impairment and functional abnormalities [13].
Genetic studies in the field of autistic disorder have mainly focused on molecular genetic
studies, assessment of chromosomal abnormalities, twin studies and family studies. In fami‐
lies having an autistic child the recurrence rate has been reported as 3-8% [14, 15, 16]. The
studies on twins and adopted children are important in identifying the actual importance of
genetic factors. Concordance among twins enables to measure heritability, and thus to as‐
sess what percentage of the phenotype is affected by genetic factors. Monozygotic (identical)
twins share 100% of the genetic material whereas dizygotic (fraternal) twins share 50% of
the genetic material. Monozygotic twins’ higher rate of concordance compared to dizygotic
twins may be used for calculation of heritability. Twin studies generally showed a higher
concordance rate for monozygotic twins compared to dizygotic twins. The concordance rate
of monozygotic twins is at least 60% when diagnostic criteria for autism (DSM-IV) are used
whereas the number is as high as 71% for autism spectrum and 92% for a broader spectrum
of verbal/social interaction disorders [11, 12, 16, 17]. On the other hand, the concordance rate
of dizygotic twins has been reported as 1-30% [9, 17-20]. Twin studies demonstrated an
average autism inheritance of 90% [21]. On the basis of these studies autism is considered to
be among the most inherited psychiatric diseases [22, 23].
Although autism has a high inheritance rate, its mode of inheritance remains unclear. Multi-
gene interactions and multiple loci are believed to play role in genetic susceptibility to the dis‐
ease [24]. There are 3 basic approaches in this area: 1) in whole genome scanning method, it is
aimed to predict the localization of a disease, about chromosomal localization of which we
have no preliminary information, by starting from common genetic determinants in a com‐
munity composed of multiplex families (families with more than one involved member). 2) cy‐
togenetic studies guide molecular studies by showing inherited or de novo chromosomal
anomalies in involved persons or families. 3) candidate gene studies examine the relationship
of genes known to affect brain development in associated regions or alternatively, a selected
precursor gene considered to hypothetically contribute to autism pathogenesis.
It has been demonstrated that structural chromosomal variations comprising also copy
number variations play an important role in etiology of autism. De novo copy number varia‐
tions have been identified in 7-10% of sporadic autism cases [25, 26].
In studies employing genome scanning method to reveal genetic etiology of autism, cogent
evidence for an association with chromosomes 2, 7, 1, and 17, especially long arm of chro‐
mosomes 2 (2q) and 7 (7q) has been obtained. Other chromosomes less associated with au‐
tism are chromosomes 1, 9, 13, 15, 19, 22, and X chromosome [14, 16, 27]. Although a lot of
genomic regions have been explored for etiology, consistent results for a limited number of
regions such as 7q11, 7q31, 22q11 have been obtained [16, 28, 29]. Particularly 15q11-q13 re‐
gion on chromosome 15 has been widely related to autism. It has been suggested that dupli‐
cations in this region of chromosome 15 may contribute to autism development. There exist
in this area a series of potential candidate genes containing gamma aminobutyric acid A
(GABAA) receptor gene complex [30]. These duplications inherited maternally have been re‐
ported to be present in 1-3% of individuals with idiopathic autism [31, 32].
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Another region related to autism is a deletion region located on chromosome 16p11. This re‐
gion has also been demonstrated to be in relationship with Asperger Syndrome, mental re‐
tardation, and developmental abnormalities [33, 34].
It has been showed that, in individuals with autism, there is a significant increase in the fre‐
quency of allelic variations of HOXA1 gene (7p15). HOXA1 and HOXB1, which have a criti‐
cal role for development of fetal caudal medullary structures, are only expressed at the third
week following fertilization, a period when neural tube is formed, and they appear to be
partly associated with development of superior olivary, facial and abducens nuclei. It has
been suggested that HOXA1 has a role in autism tendency and is associated with early
phase of brain stem development in autism etiology [16, 35]. On the other hand, there are
studies where no significant association with HOXA1 gene variants and autism could be
demonstrated [36, 37].
Engrailed-2 (EN-2) which is the human homologue of drosophila engrailed gene and located
on the long arm of Chromosome 7 (7q36) is a homeobox gene having a critical role in mid‐
brain and cerebellar development. Temporal and spatial pattern of engrailed gene expres‐
sion occurs simultaneously with the development of cerebellar precursor cells. Thus, it has
been suggested to be important to determine correct cell number in cerebellum [38]. Petit
and his colleagues (1995) reported a significant association between Pvull polymorphism at
the 5’ region of EN-2 gene and autism [39]. However, this association could not be con‐
firmed in a later family study [40].
MET oncogene coding pleiotropic MET receptor thyrosine kinase is located on the long arm
of Chromosome 7. MET signalization has a role in neocortex and cerebellar growth and ma‐
turation, and immune functions. MET gene and its ligand, hepatocyte growth factor (HGF),
have been related to autism. Studies conducted by Campbell and his colleagues ([41,42]
showed that C allele in the promoter region of MET gene decreases MET promoter activity
by two fold and decreased MET gene expression is associated with autism tendency.
Another gene on Chromosome 7 is  CNTNAP2 (contactin-associated-protein-like 2)  gene.
CNTNAP2 gene has been associated in various studies with autism, language delay, and
epilepsy [43-45].
FOXP2 (forkhead box P2), a forkhead transcription factor gene, is a member of family fork‐
head known as the key regulators of embryogenesis; it encodes a transcription factor con‐
taining polyglutamine and is associated with development of lingual functions. In a study in
Chinese society, FOXP2 gene located in the 7q31 region was linked with autism pathogene‐
sis [46]. However, other studies did not replicate these findings [47, 48].
Another gene investigated for autism relationship is Wingless-Int (Wnt2) gene located on
the long arm of Chromosome 7 (7q31-33). Wnt genes encode glycoproteins rich in cysteine,
which regulate various cellular movements during the embryonic development [49]. It has
been shown that Wnt has a role in regulation of activity-dependent dendritic branching in
hippocampal pyramidal neurons [50]. Wnt2 gene was linked with autism in a study by Was‐
sink and his colleagues [51].
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Reelin is an important extracellular matrix glycoprotein that has an important role in devel‐
opment of neuronal migration, lamination, and connection during embryonic brain develop‐
ment and is associated with a signal pathway forming the basis of neuro-conduction,
memory formation, and synaptic plasticity [52]. It is responsible for lamination in embryonic
period whereas it has a role in cell signalization and synaptic plasticity in adulthood period
[53]. Decrease in reelin expression has been associated with autism. RELN gene, which is lo‐
cated in 7q22 region and encodes reelin protein which is important in neurodevelopment,
involves a polymorphic GGC repeat in 5’ region. Long GGC alleles of RELN gene cause
blunt gene expression; therefore, they are considered to be linked with autism [52]. There
are studies reporting a significant relationship between RELN alleles with larger numbers of
CGG repeats and autism [52, 54] while there are also negative studies in terms of such a rela‐
tionship [55]. Besides the genetic complexity in the etiopathogenesis of this disorder, non-
replication of the results of different studies should also be taken into consideration.
Neuroligins are cellular adhesion molecules located at the postsynaptic side of the synapse.
Neuroligins and neuroxins, neuronal cell surface proteins, form an asymmetrical intercellular
connection by adhering to each other. Interaction of neuroligins with beta neuroxins forms
functional synapses [56]. Neuroligin family is composed of 5 members, i.e. NLGN1, NLGN2,
NLGN3, NLGN4, and NLGN4Y. Although all of the neuroligin family is linked with autism
spectrum disorder [57], the most robust evidence comes from NLGN3 (Xq13) and NLGN4
(Xp22.3) genes. Jamain and colleagues [58] found that mutations in NLGN3 and NLGN4, two
X-linked neuroligin genes, are associated with autism spectrum disorders [58]. Following this,
it has been demonstrated that a 2-base-pair deletion in NLGN4 gene causes premature stop co‐
don in mental-retarded men with or without autism. This finding indicates that NLGN4 gene is
not only associated with autism, but also with mental retardation [59]. Since mutations in neu‐
roligin genes impair the functions of synaptic cell adhesion molecules, they are considered to
be related with autism and neurodevelopmental defects in mental retardation [60]. Since neu‐
roligins are abundant particularly in excitatory synapses, a defect in synaptogenesis has been
suggested to result in derangement in cognitive development and communication [59]. None‐
theless, some other studies revealed negative results [61].
Genetic studies examining the relationship of neuroxins, the connection partners of neuroli‐
gins, with autism revealed that a mutation in neuroxin 1beta gene results in autism susceptibil‐
ity [62]. Structural variants of neuroxin 1alpha gene have also been linked with autism [63].
Another protein adhering to neuroligins is SHANK3. Some forms of autism are considered
to stem from a single gene, and particularly from a rare allele having a major effect. Doctor
Joseph Buxbaum has reported that one of these genes is SHANK3 gene located on Chromo‐
some 22 (22q13) which is responsible for 1% of autism and some forms of mental retarda‐
tion, microcephaly, and delay in expressive language [34]. SHANK proteins are believed to
be the primary regulator of postsynaptic density thanks to their ability to form multimeric
complexes with postsynaptic receptors, signal molecules, and cellular skeleton proteins
found in dendritic spikes. Postsynaptic density is the measurement of how synapses are
linked to each other. A mutation in SHANK3 gene has been reported to be related with au‐
tism spectrum disorders [64]. Role of various mutations in Neuroligin/neuroxin/SHANK3
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complex in development of autism spectrum disorders provide potential evidence for syn‐
aptic alterations in etiology of the disorder.
A large-scale study by Wang and his colleagues [65] revealed a significant relationship be‐
tween a single nucleotide polymorphism located in the 5p14.1 region and autism spectrum
disorders. The associated single nucleotide polymorphism is located in a region placed be‐
tween cadherin 10 (CDH 10) and cadherin 9 (CDH 9) genes. CDH 9 and CDH 10 encode
type II classic cadherins of the cadherin family, which are transmembraneous glycoprotiens
responsible for calcium-dependent cell-cell adhesion. This finding shows the role of neuro‐
nal cellular adhesion molecules in autism pathogenesis [65].
Neurotrophins have many functions such as neuronal survival, target innervation, and synap‐
togenesis in development of peripheral and central nervous system. Neurotrophins exert their
biologic functions by binding to a Trk tyrosine kinase receptor which is a high-affinity recep‐
tor. Neurotrophin family has 4 members. These are nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin-3 and neurotrophin-4. BDNF is the most important
member of neurotrophin family. BDNF has many roles in neuronal differentiation such as neu‐
ronal survival, dendritic and axonal growth/branching, synapse formation, and neuronal plas‐
ticity [66, 67]. Various studies have investigated the relationship between BDNF gene and
autism. Nishimura and colleagues [68] detected an increase in BDNF expression in autistic in‐
dividuals. Subsequent studies confirmed the potential role of BDNF gene mutations in autism
pathogenesis [69]. A recent study in which serum BDNF levels significantly increased in autis‐
tic children found no significant impact of genetic variations of BDNF gene on autism risk;
however,  a significant relationship between neurotrophic tyrosine kinase receptor type 2
(NTRK2) and autism was reported [70]. A large-scale study on patients diagnosed with autism
spectrum disorder and mental retardation without autism diagnoses showed that, when com‐
pared to control group, autism spectrum disorders and mental retardation had a significant in‐
crease in serum neurotrophin 4 and BDNF (both are Trk B ligands) [71, 72]. On the other hand,
no changes were observed in NGF (trk A ligand) and neurotrophin 3 (Trk C ligand) levels. In
light of these findings, it has been suggested that trkB ligands may be overexpressed or secret‐
ed in central nervous system of autistic or mental retarded children during infantile period. It
has also been suggested that the effect of BDNF and neurotrophin- 4 on activity-dependent
dendritic growth and branching [66] may be related to early and transient brain development
seen in autistic infants [67, 73]. This increase in BDNF expression and/or secretion was suggest‐
ed to be linked with the role of Metil-CpG-binding protein 2 (MeCP2) gene in BDNF transcrip‐
tion  [74].  A  mutation  in  MeCP2  gene  encoding  a  protein  functioning  as  a  general
transcriptional receptor is responsible for Rett Syndrome. It has been shown that MeCP2 selec‐
tively bind to BDNF promoter III and suppresses BDNF gene expression. MeCP2 has an impor‐
tant role in regulation of neuronal activity [75]. It has been suggested that MeCP2 mutations
located on Xq28 locus may be a risk factor for autism by affecting BDNF expression and den‐
dritic differentiation in cortex. In a study investigating MeCP2 gene mutation in autistic indi‐
viduals for that purpose, 2 girls exhibited de novo mutations [67, 76].
Another gene linked with autism is the Fragile X mental retardation 1 (FMR1) gene encoding
Fragile X mental retardation protein (FMRP). FMR1 is associated with autism secondary to
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Fragile X syndrome [28]. However, fragile X mutations may be found in 7-8% idiopathic au‐
tism patients [77]. FMRP is a selective RNA-binding protein; it transports RNAs to dendrites
and regulates local translation of synaptic mRNAs as a response to activation of metabotropic
glutamate receptors. This protein is considered to have a role in synaptic plasticity and devel‐
opment of synaptic connections between neural cells. Impaired mRNA translation in the ab‐
sence of FMRP leads to an alteration in protein-synthesis-dependent plasticity [28, 78].
Autism risk is higher than general population in neurofibromatosis, tuberosclerosis, or Cow‐
den Syndrome, a rare syndrome which is characterized by multiple tumor-like growths
called hamartomas and affects the intellectual abilities. These diseases develop due to domi‐
nant mutations in tumor suppressor genes NF1, TSC1/TSC2, and PTEN. Mutations in these
autism-associated genes affect synaptic protein level by impairing cellular translation. Alter‐
ations in protein level results in abnormal synaptic functions [28].
Angelman syndrome and Prader-Willi syndrome mainly develop due to genetic deletions in
15q11-q13 locus or disomy (condition where two copies of a chromosome comes from a sin‐
gle parent) belonging to a single parent [79]. Deficiencies in paternal genes cause Prader-
Willi syndrome; Angelman Syndrome which is more commonly associated with autism may
be caused by deletion or mutation in maternal ubiquitin protein ligase gene UBE3A or
ATP10C [80, 81]. Other rare single gene defects associated with autism are found in Wil‐
liams Syndrome, Sotos Syndrome, hipomelanozis Ito, and Moebius Syndrome [82-85].
Since serotonin reuptake inhibitors have favourable effects on rituals and routines in autistic
individuals and serotonin transporter gene has important role in serotonergic neurotrans‐
mission, serotonin transport gene has been investigated as candidate gene in autism. One of
the polymorphisms examined in this gene is the one that is formed by long (L) and short (S)
alleles owing to different number of insertion/deletion repeats of a 44-base-pair sequence in
the transcriptional control region. Cook and his colleagues [86] reported a significant rela‐
tionship between autism and short allele while Klauck and his colleagues [87] revealed a
significant relationship between autism and long allele. A subsequent study did not dupli‐
cate these findings [88]. A different polymorphism investigated at the serotonin transport
gene is the variable number of tandem repeats (VNTR) polymorphism due to repeat of a 17-
base-pair region at 2nd intron of the gene 9,10, and 12 times. This polymorphism could not
be related to autism [89]. Evidence has been accumulated on the relationship of many sero‐
tonin genes, notably serotonin receptor (HTR) 1B, HTR2A, HTR3A, and HTR5A, with au‐
tism [90-93].
Glutamate is the main excitatory neurotransmitter associated with cognitive functions such
as memory and learning. Autism has been hypothesized as a hypoglutamatergic disorder by
virtue of neuroanatomic studies and the similarities glutamate antagonists generate in
healthy persons [94]. It has been demonstrated in genome scanning studies that one of the
candidate regions for autism is 6q21 region [95]. This region contains glutamate receptor 6
(GluR6) gene. A study by Jamain and his colleagues [96] found a significant relationship be‐
tween GluR6 gene and autism. It has been thought that GluR6 dysfunction may contribute
the deterioration of communication and learning process in autism and any dysregulation of
GluR expression may be related to an increase in the rate of epileptic disorder in autistic
Recent Advances in Autism Spectrum Disorders - Volume I326
children [96]. Other glutamatergic receptor genes associated with autism are metabotropic
GluR8 and GRIN2A (glutamate receptor, ionotropic, N-methyl-D-aspartate 2A) [97, 98].
Gama aminobutyric acid (GABA) is the major inhibitor neurotransmitter in the brain. GABAA
receptors are formed by different homologous subunits. Among GABA receptor subunit genes,
GABRA4 with 4p12 location has been shown to play a role in etiology of autism and increases au‐
tism risk by interaction with GABRB1 [99]. Other genes associated with autism in some other
studies are GABRG3, GABRA5, GABRB3 located on 15q11-q13, and GABRA2 located on 4p
[100-102]. Contrary to these findings, there are other studies with negative results in terms of the
relationship between GABA receptor genes and autism in various ethnic groups [103].
Proenkephalin, prodinorphine of opioid metabolism; tyrosine hydroxylase, dopamin beta
hydroxylase (DBH), D2, D3, and D5 dopamin receptors, monoaminooxidase A (MAOA) and
B genes of monoaminergic system have no major role in etiology of autism shown in studies
[104, 105]. However, a recent study revealed a significant relationship between MAOA gene
and autism [106].
Mutations detected in autism in conjunction with all other genetic factors explored so far
have been reported to explain no more than 20% of cases with autism spectrum disorder.
Thus, a gene-dosage model has been proposed according to which the susceptibility for au‐
tism is determined by the sum of effects of threshold genetic and non-genetic factors [107,
108]. For autism etiology, it has been suggested that the detected chromosomal abnormali‐
ties in combination with other undetected loci cause autism. It has been considered that the
inconsistencies between the results of the studies aimed to determine the role of genetic fac‐
tors may be the product of genetic heterogeneity, clinical heterogeneity, and sample size and
ethnic differences among different studies [109].
3. Environmental risk factors
In addition to effects of a number of genes of small effect, various environmental factors are
believed to be responsible for susceptibility to autism. Development of autism seems to be
dependent on interaction of susceptibility genes with each other and with the environment
[110]. It has been claimed that among environmental factors related to autism are toxins (en‐
vironment-polluting matters, insecticides, thimerosal in vaccines, lead), viruses (prenatal ex‐
posure to influenza, rubella, and cytomegalovirus infections), and premature birth with
premature retinopathy [111-115]. Although there has been a debate regarding the relation‐
ship of autism with thimerosal in measles, rubella, and mumps vaccines; further careful
evaluation of data could not support the relationship between autism and vaccines [116,
117]. The relationship between exposure to Rh immune globulin, which contained the pres‐
ervative thimerosal until 2001 in the United States, and autism has also been investigated;
however, no significant association has been revealed between exposure of antepartum RhIg
preserved with thimerosal and an increase in risk of autistic disorder. The latter findings are
in accordance with the consensus that exposure to ethymercury in thimerosal is not the
cause of increased prevalence of autism [118].
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Other factors related to intrauterine environment are maternal hypothyroxinemia [119], ma‐
ternal influenza [120], and high levels of sex hormone exposure related to infertility treat‐
ment [121].Thalidomide and anticonvulsant exposure in pregnancy is correlated to an
increase in autism risk [122, 123]. Rasalam and his colleagues [124] showed that 8.9% of chil‐
dren exposed to sodium valproate in intrauterine life later develop autistic spectrum disor‐
ders such as autism or Asperger syndrome. Recently, Hadjikhani [125] have suggested that
serotonin reuptake inhibitor use in pregnancy increases autism risk by causing hyperseroto‐
ninemia and indirectly affecting amygdala and oxytocin levels.
In many studies, the pre-perinatal complication rates in autistic disorder have been studied
and a higher pregnancy-related complication rate has been demonstrated in autistic children
[126, 127]. In a recent meta-analysis [128], the most strong risk factors for autism were ad‐
vanced maternal and paternal age, maternal gestational hemorrhage, gestational diabetes, ma‐
ternal prenatal drug use (particularly psychoactive drugs), and birth in a foreign country
following immigration of mother. Both advanced maternal and paternal age are associated
with autism. The underlying mechanism is unclear. Maternal age may be related to autism due
to increased risk of chromosomal abnormalities in ova of increased age or because of unstable
trinucleotide repeats [128]. The relationship between paternal age and autism is considered to
result from imprinted genes (genes showing different expression patterns depending on the
parent it originates), de novo spontaneous mutations that accumulate with advancing age in
spermatagonia, or confounder effects of sociocultural environmental factors [129]. Another po‐
tential risk factor for autism is maternal birth abroad [130]. It has been suggested that this factor
may result from absence of immunization that mother would develop against widespread in‐
fectious agents of the country in which she gives birth. Another possible explanation is about
the potential role of maternal stress because of immigration [131]. A more detailed investiga‐
tion on the relationship between mother immigration and autism is needed. It has been demon‐
strated in some studies that gestational hemorrhage increases autism risk by causing fetal
hypoxia [130]. Among other factors considered to cause hypoxia and associated with increased
autism risk in some studies are fetal distress, maternal hypertension, prolonged labor, cord
complications, low Apgar score, and cesarean section [132]. Gestational diabetes is another risk
factor, with unknown biologic mechanism [128].
Some studies demonstrated that prenatal stress increases autism risk [133, 134]. However,
due to limitations that these studies are based on retrospective expressions of mothers and
these mothers are generally susceptible for experiencing stressful life events outside preg‐
nancy period, these studies need to be supported by further studies. Spontaneous abortions,
pre-perinatal complications, congenital anomalies, and neurologic/immunologic abnormali‐
ties are among the negative impacts of prenatal stress. Prenatal stress also has various nega‐
tive effects on brain development such as a delay in myelinization, an increase in sensitivity
of amygdala to glucocorticoids, and abnormal development in dopaminergic system
[135-137]. Autistic disorder is associated with a functional derangement in brain areas relat‐
ed to social cognitive functions in which amygdala and orbitofrontal cortex plays an impor‐
tant role. Orbitofrontal cortex is susceptible to effects of prenatal stress especially in the
middle of gestation. Normal functioning of orbitofrontal cortex - amygdala axis is very im‐
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portant for social cognitive function. Therefore, it has been suggested that damage in orbito‐
frontal region may cause main deficits in autism that underlies inadequate responses to
other people’s mental status and that impairs self-organization of social-emotional behav‐
iours [137, 138]. Prenatal stress may impair brain development by many mechanisms includ‐
ing: a) fetal hypoxia due to reducing of uterine and placental circulation, b) impairment of
hypothalamus-hypophysis-adrenal axis by stimulation of secretion of maternal stress hor‐
mones that can cross placenta, c) generation of pregnancy and birth complications, d) epige‐
netic effects on expression of stress response-related genes [137].
It has been reported that exposure of environmental stress factors at 21-32nd weeks with a
prominent peak at 25-28th weeks is associated with an increase in possibility of development
of autism [134]. When data regarding progressively worsening developmental process are
considered [139], it has been argued that postnatal environmental exposures in genetically
susceptible children may be etiologically important [140]. Expression and the impact of
many genes is influenced by environmental factors. Thus, the effect of environmental factors
in etiology of autism is believed to be indirect by influencing genetic functions [140, 141].
4. Conclusion
In line with studies aimed to understand the neurobiology of autism, the presence of altera‐
tions in regional brain anatomy and functional neuronal communicative network has been
currently proved. The main role among factors underlying abnormal brain development be‐
longs to genetic factors. Evidence regarding that autism is a primarily genetic disorder is
progressively increasing. Although environmental factors alone can explain a few cases,
they are believed to increase autism risk by interacting with genetic susceptibility. Although
data collected so far contribute to the ever-increasing body of knowledge about neurobiolo‐
gy of autism, they do not influence diagnosis and treatment of autism. Use of these data is
aimed in future in differentiation of autism from other neurodevelopmental disorders and
in diagnostic and therapeutic processes.
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